• 1
    Grosvenor M, Bulcavage L, Chlebowski RT. Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 1989; 63: 3304.
  • 2
    Kotler DP. Cachexia. Ann Intern Med 2000; 133: 62234.
  • 3
    Cooperman AM, Chivati J, Chamberlain RS. Nutritional and metabolic aspects of pancreatic cancer. Curr Opin Clin Nutr Metab Care 2000; 3: 1721.
  • 4
    Capra S, Ferguson M, Ried K. Cancer: impact of nutrition intervention outcome–nutrition issues for patients. Nutrition 2001; 17: 76972.
  • 5
    Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 66171.
  • 6
    Marks DL, Ling N, Cone RD. Role of the central melanocortin system in cachexia. Cancer Res 2001; 61: 14328.
  • 7
    Mantovani G, Maccio A, Esu S, et al. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur J Cancer 1997; 33: 6027.
  • 8
    Tisdale MJ. Cancer anorexia and cachexia. Nutrition 2001; 17: 43842.
  • 9
    Wyke SM, Tisdale MJ. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 2005; 92: 71121.
  • 10
    Acharyya S, Ladner KJ, Nelsen LL, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114: 3708.
  • 11
    Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001; 85: 297302.
  • 12
    Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000; 289: 23636.
  • 13
    Suttmann U, Holtmannspotter M, Ockenga J, Gallati H, Deicher H, Selberg O. Tumor necrosis factor, interleukin-6,and epinephrine are associated with hypermetabolism in AIDS patients with acute opportunistic infections. Ann Nutr Metab 2000; 44: 4353.
  • 14
    Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287: C83443.
  • 15
    ASPEN Board of Directors and Clinical Guideline Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr 2002; 26.
  • 16
    Arends J, Bodoky G, Bozzetti F, et al. ESPEN Guidelines on Enteral Nutrition in Oncology. Clinical Nutrition 2005.
  • 17
    Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003; 22: 41521.
  • 18
    Baker JP, Detsky AS, Wesson DE, et al. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982; 306: 96972.
  • 19
    Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 813.
  • 20
    Arends J, Zürcher G, Fietkau R, et al. DGEM Leitlinie Enterale Ernährung: Onkologie. Aktuelle Ernährungsmedizin 2003; 28: S618.
  • 21
    Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 2004; 100: 196777.
  • 22
    Norman HA, Butrum RR, Feldman E, et al. The role of dietary supplements during cancer therapy. J Nutr 2003; 133: 3794S9S.
  • 23
    Nightingale JM. The medical management of intestinal failure: methods to reduce the severity. Proc Nutr Soc 2003; 62: 70310.
  • 24
    Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81: 806.
  • 25
    Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52: 147986.
  • 26
    Ockenga J, Pirlich M, Gastell S, Lochs H. Tumour anorexia - tumour cachexia in case of gastrointestinal tumours: -standards and visions. Z Gastroenterol 2002; 40: 92936.
  • 27
    Nixon DW, Lawson DH, Kutner M, et al. Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res 1981; 41: 203845.
  • 28
    Smedley F, Bowling T, James M, et al. Randomized clinical trial of the effects of preoperative and postoperative oral nutritional supplements on clinical course and cost of care. Br J Surg 2004; 91: 98390.
  • 29
    Barsevick AM, Dudley W, Beck S, Sweeney C, Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 2004; 100: 130210.
  • 30
    Mantovani G, Maccio A, Massa E, Madeddu C. Managing cancer-related anorexia/cachexia. Drugs 2001; 61: 499514.
  • 31
    Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993; 11: 1524.
  • 32
    Desport JC, Gory-Delabaere G, Blanc-Vincent MP, et al. Standards, options and recommendations for the use of appetite stimulants in oncology (2000). Br J Cancer 2003; 89 (Suppl 1): S98S100.
  • 33
    Bruera E, Neumann CM, Pituskin E, Calder K, Ball G, Hanson J. Thalidomide in patients with cachexia due to terminal cancer: preliminary report. Ann Oncol 1999; 10: 8579.
  • 34
    Goldberg RM, Loprinzi CL, Mailliard JA, et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995; 13: 28569.
  • 35
    McMillan DC, Wigmore SJ, Fearon KC, O'Gorman P, Wright CE, McArdle CS. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 1999; 79: 495500.
  • 36
    Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non- small-cell lung cancer. J Clin Oncol 1987; 5: 11324.
  • 37
    Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993; 11: 20439.
  • 38
    Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology 2001; 121: 9701001.
  • 39
    Margolis M, Alexander P, Trachiotis GD, Gharagozloo F, Lipman T. Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg 2003; 76: 16947.
  • 40
    Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient’ outcomes: a prospective randomized controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005; 23: 14318.
  • 41
    Sinclair JJ, Scolapio JS, Stark ME, Hinder RA. Metastasis of head and neck carcinoma to the site of percutaneous endoscopic gastrostomy: case report and literature review. JPEN J Parenter Enteral Nutr 2001; 25: 2825.
  • 42
    Dormann AJ, Glosemeyer R, Leistner U, et al. Modified percutaneous endoscopic gastrostomy (PEG) with gastropexy – early experience with a new introducer technique. Z Gastroenterol 2000; 38: 9338.
  • 43
    Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet 2001; 358: 148792.
  • 44
    Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229: 46777.
  • 45
    Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di CV. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122: 176370.
  • 46
    Gianotti L, Braga M, Frei A, Greiner R, Di CV. Health care resources consumed to treat postoperative infections: cost saving by perioperative immunonutrition. Shock 2000; 14: 32530.
  • 47
    Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer 2004; 12: 24652.
  • 48
    Bozzetti F, Cozzaglio L, Biganzoli E, et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 2002; 21: 2818.
  • 49
    Cozzaglio L, Balzola F, Cosentino F, et al. Outcome of cancer patients receiving home parenteral nutrition. Italian Society of Parenteral and Enteral Nutrition (S.I.N.P.E.). JPEN J Parenter Enteral Nutr 1997; 21: 33942.
  • 50
    Bachmann P, Marti-Massoud C, Blanc-Vincent MP, et al. Summary version of the standards, options and recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer 2003; 89(Suppl. 1): S10710.
  • 51
    Bozzetti F, Amadori D, Bruera E, et al. Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Nutrition 1996; 12: 1637.
  • 52
    Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001; 9: 22333.
  • 53
    Orrevall Y, Tishelman C, Herrington MK, Permert J. The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 2004; 23: 12807.
  • 54
    Schmiegel W, Pox C, Adler G, et al. S3-Guidelines Conference ‘‘Colorectal Carcinoma’’ 2004. Z Gastroenterol 2004; 42: 112977.
  • 55
    Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003; 53: 26891.
  • 56
    Ferguson LR, Harris PJ. The dietary fibre debate: more food for thought. Lancet 2003; 361: 14878.
  • 57
    Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003; 361: 14915.